Selinexor and Backbone Treatments of Multiple Myeloma Patients

NCT02343042 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Pomalidomide
DRUG: Bortezomib
DRUG: Daratumumab
DRUG: Carfilzomib
DRUG: Ixazomib
DRUG: Elotuzumab
DRUG: Clarithromycin
DRUG: Belantamab Mafodotin
DRUG: Mezigdomide

Sponsor

Karyopharm Therapeutics Inc

Collaborators

[object Object]